Mini-Oral Session

[MO20] Mini-Oral Session 20　Translational Research / Clinical Pharmacology 3（Biomarker）
【E】

Fri. Feb 18, 2022 8:20 AM - 9:10 AM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair：Hiroshi Ishiguro（Breast Oncology Service, Saitama Medical University International Medical Center），Natsuko Chiba（Department of Cancer Biology, Institute of Development, Aging and Cancer, Tohoku University）

+Add all to schedule

[MO20-1] Characterization of OASEP1 as a potential prognostic biomarker and therapeutic target for oral cancer

^○Atsushi Takano^1,2,3, Yoshihiro Yoshitake⁴, Masanori Shinohara⁴, Yataro Daigo^1,2,3 (1.Ctr. Antibody and Vaccine Ther, Inst. Med. Sci., Univ. of Tokyo, 2.Dep. Med. Oncol. & Cancer Ctr., Shiga Univ. Med. Sci., 3.Ctr. Advanced Med. against Cancer, Shiga Univ. of Med. Sci., 4.Dept. of Oral and Maxillofacial Surg. Kumamoto Univ.)

[MO20-2] Efficacy of Immune Checkpoint Inhibitors for Gastrointestinal Cancers with SWI/SNF Complex Genetic Alterations

^○Akinobu Nakata¹, Yukiya Narita¹, Ryosuke Kumanishi¹, Taiko Nakazawa¹, Takatsugu Ogata¹, Yuki Matsubara¹, Hiroyuki Kodama¹, Kazunori Honda¹, Toshiki Masuishi¹, Hiroya Taniguchi¹, Shigenori Kadowaki¹, Masashi Ando¹, Rui Yamaguchi², Masahiro Tajika³, Kei Muro¹ (1.Department of Clinical Oncology, Aichi Cancer Center Hospital, 2.Division of Cancer Systems Biology, Aichi Cancer Center Institute, 3.Department of Endoscopy, Aichi Cancer Center Hospital)

[MO20-3] Caffeic acid phenethyl ester suppresses drug resistance of enzalutamide or abiraterone in prostate cancer cells

^○Chih-Pin Chuu, Ying-Yu Kuo, Chieh Huo (Institute of Cellular and System Medicine, National Health Research Institutes, Taiwan)

[MO20-4] BRCA1-mediated transactivation causes resistance to PARP inhibitors without affecting homologous recombination activity

^○Natsuko Chiba, Yuki Yoshino, Shino Endo (Department of Cancer Biology, IDAC, Tohoku University)

[MO20-5] KRAS inhibitor-resistance in MET-amplified KRASG12C NSCLC induced by RAS- and non-RAS-mediated cell signaling mechanisms

^○Shinichiro Suzuki (Department of Medical Oncology, Kindai University Faculty of Medicine)

[MO20-6] CADM1 and SPC25 gene mutations in lung cancer patients with idiopathic pulmonary fibrosis

^○Aya Fukuizumi¹, Rintaro Noro¹, Masahiro Seike¹, Akihiko Miyanaga¹, Yuji Minegishi¹, Miwako Omori¹, Mamiko Hirao¹, Kuniko Matsuda¹, Shinobu Kunugi², Kazutaka Nishiwaki³, Masahiro Morimoto³, Haruka Motohashi³, Hayato Ohwada³, Jitsuo Usuda⁴, Akihiko Gemma¹ (1.Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 2.Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, 3.Department of Industrial Administration, Faculty of Science and Technology, Tokyo University of Science, 4.Department of Thoracic Surgery, Graduate School of Medicine, Nippon Medical School)